Induction therapy in lung transplantation: A contemporary analysis of trends and outcomes.

Larisa Shagabayeva Asishana A OshoPhilicia MoonsamyNavyatha MohanSelena Shi-Yao Li Stanley WolfeNathaniel B LangerMasaki FunamotoMauricio A Villavicencio

Published in: Clinical transplantation (2022)

Induction therapy for lung transplant recipients-specifically basiliximab-is associated with improved long-term survival and a lower risk of renal failure or acute rejection.

Keyphrases

liver failure
respiratory failure
extracorporeal membrane oxygenation
drug induced
type diabetes
stem cells
intensive care unit
metabolic syndrome
hepatitis b virus
mechanical ventilation